ETI
CNMD icon

Enterprise Trust & Investment’s CONMED CNMD Stock Holding History

Enterprise Trust & Investment’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$2K Buy
+24
New +$2.88K ﹤0.01% 338

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Enterprise Trust & Investment's CNMD Position: Q2 2022 in Review

Enterprise Trust & Investment opened a new position in CONMED (CNMD) in Q2 2022: 24 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #338 among its holdings.

280 funds tracked by Wall St. Rank hold CNMD as of Q2 2022.

  • Enterprise Trust & Investment held 24 shares of CONMED worth $2K as of Q2 2022.
  • CONMED was a new Enterprise Trust & Investment position in Q2 2022.
  • CONMED made up ﹤0.01% of Enterprise Trust & Investment's portfolio in Q2 2022, its #338 holding.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.